Short Interest in Ion Beam Applications SA (OTCMKTS:IOBCF) Rises By 129.9%

Ion Beam Applications SA (OTCMKTS:IOBCF) was the target of a large growth in short interest in the month of January. As of January 30th, there was short interest totaling 2,138 shares, a growth of 129.9% from the January 15th total of 930 shares. Based on an average trading volume of 414 shares, the short-interest ratio is presently 5.2 days. Based on an average trading volume of 414 shares, the short-interest ratio is presently 5.2 days.

Ion Beam Applications Stock Performance

OTCMKTS:IOBCF remained flat at $18.15 on Thursday. The company’s fifty day moving average is $15.46 and its two-hundred day moving average is $14.43. Ion Beam Applications has a 52-week low of $10.15 and a 52-week high of $19.00.

Ion Beam Applications Company Profile

Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.

In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.